27th Hong Kong Medical Forum

According to data presented at HKMF 2023, transient elastography (TE) is preferred for noninvasive assessment of fibrosis for patients with chronic liver diseases (CLDs) in Hong Kong. Liver stiffness measurement (LSM) using noninvasive tests (NITs) can be repeated annually to monitor disease progression in patients with compensated advanced CLDs (cACLDs).

Statin therapy, as well as triple antihypertensive combination therapy, may reduce the risk of recurrence in patients who have survived an intracerebral haemorrhage (ICH), according to new local findings presented at HKMF 2023.